Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Expert Opinion on Drug Metabolism & Toxicology
|
June 28, 2013
Evaluation of lorcaserin for the treatment of obesity
Helen D Berlie, Kathryn M Hurren
The Annals of Pharmacotherapy
|
March 11, 2010
Diabetes medications related to an increased risk of falls and fall-related morbidity in the elderly
Helen D Berlie, Candice L Garwood
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
October 21, 2011
Lorcaserin: an investigational serotonin 2C agonist for weight loss
Kathryn M Hurren, Helen D Berlie
Ethnicity & Disease
|
November 7, 2007
Health issues in the Arab American community. The use of glucose-lowering agents and aspirin among Arab Americans with diabetes
Helen D Berlie, Adnan Hammad, Linda A Jaber
Diabetes Research and Clinical Practice
|
October 24, 2006
Thiazolidinediones and the risk of edema: a meta-analysis
Helen D Berlie, James S Kalus, Linda A Jaber
Clinical Pharmacology in Drug Development
|
May 4, 2018
Does Dapagliflozin Affect Energy Intake and Appetite? A Randomized, Controlled Exploratory Study in Healthy Subjects
Elizabeth Bertran, Helen D Berlie, Aaron Nixon, et al.
American Journal of Pharmaceutical Education
|
May 21, 2020
Cultivating a Vibrant and Thriving Elective Curriculum in Pharmacy Schools
Helen D Berlie, Kristin K Janke, Candice L Garwood
Clinical Diabetes : a Publication of the American Diabetes Association
|
July 17, 2024
Accidental Once-Daily Use of Dulaglutide: A Case Report
Hannah E Moore, Viva Zaya, Carly V Burns, et al.
The Annals of Pharmacotherapy
|
May 24, 2007
Evolution of peroxisome proliferator-activated receptor agonists
Feng Chang, Linda A Jaber, Helen D Berlie, et al.
The Annals of Pharmacotherapy
|
March 4, 2021
Mechanisms and Potential Roles of Glucose-Lowering Agents in COVID-19: A Review
Helen D Berlie, Pramodini B Kale-Pradhan, Tara Orzechowski, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Expert Opinion on Drug Metabolism & Toxicology
|
June 28, 2013
Evaluation of lorcaserin for the treatment of obesity
Helen D Berlie, Kathryn M Hurren
The Annals of Pharmacotherapy
|
March 11, 2010
Diabetes medications related to an increased risk of falls and fall-related morbidity in the elderly
Helen D Berlie, Candice L Garwood
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
October 21, 2011
Lorcaserin: an investigational serotonin 2C agonist for weight loss
Kathryn M Hurren, Helen D Berlie
Ethnicity & Disease
|
November 7, 2007
Health issues in the Arab American community. The use of glucose-lowering agents and aspirin among Arab Americans with diabetes
Helen D Berlie, Adnan Hammad, Linda A Jaber
Diabetes Research and Clinical Practice
|
October 24, 2006
Thiazolidinediones and the risk of edema: a meta-analysis
Helen D Berlie, James S Kalus, Linda A Jaber
Clinical Pharmacology in Drug Development
|
May 4, 2018
Does Dapagliflozin Affect Energy Intake and Appetite? A Randomized, Controlled Exploratory Study in Healthy Subjects
Elizabeth Bertran, Helen D Berlie, Aaron Nixon, et al.
American Journal of Pharmaceutical Education
|
May 21, 2020
Cultivating a Vibrant and Thriving Elective Curriculum in Pharmacy Schools
Helen D Berlie, Kristin K Janke, Candice L Garwood
Clinical Diabetes : a Publication of the American Diabetes Association
|
July 17, 2024
Accidental Once-Daily Use of Dulaglutide: A Case Report
Hannah E Moore, Viva Zaya, Carly V Burns, et al.
The Annals of Pharmacotherapy
|
May 24, 2007
Evolution of peroxisome proliferator-activated receptor agonists
Feng Chang, Linda A Jaber, Helen D Berlie, et al.
The Annals of Pharmacotherapy
|
March 4, 2021
Mechanisms and Potential Roles of Glucose-Lowering Agents in COVID-19: A Review
Helen D Berlie, Pramodini B Kale-Pradhan, Tara Orzechowski, et al.
Page
of 2